Search Within

Heiko Schoder

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (73)
  2. Meeting Abstract (41)
  3. Book Section (4)
  4. Editorial (2)
  5. Review (2)
Groups
  1. Molecular Imaging and Therapy Service (122)
  2. Molecular Pharmacology and Chemistry Program Faculty (122)
  3. Radiology, Department of (122)
  4. Sloan Kettering Institute Faculty (122)
  5. GSK Faculty (117)
  6. Department of Medicine (58)

More Groups

People
  1. Steven Larson (93)
  2. John Humm (32)
  3. Mithat Gonen (27)
  4. Henry Yeung (22)
  5. Howard Scher (22)
  6. Josef Fox (20)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (6)
  4. 2022 (1)
  5. 2021 (3)
  6. 2020 (4)

More Years

Publications
  1. Journal of Nuclear Medicine (37)
  2. Journal of Clinical Oncology (20)
  3. European Journal of Nuclear Medicine and Molecular Imaging (8)
  4. International Journal of Radiation Oncology, Biology, Physics (5)
  5. Medical Physics (5)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. Society of Nuclear Medicine (37)
  2. American Society of Clinical Oncology (20)
  3. Springer (16)
  4. Elsevier Inc. (11)
  5. Lippincott Williams & Wilkins (7)
  6. American Association of Physicists in Medicine (5)

More Publishers

Results (122)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in locally advanced gastroesophageal junction and gastric adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Kelsen, D. P.; Strong, V. E.; Schöder, H.; Janjigian, Y. Y.; Shah, M. A.; Coit, D. G.; Brennan, M. F.; Capanu, M.; Ilson, D. H.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Post-treatment alterations in 18F-dihydrotestosterone (FDHT) and FDG PET/CT in metastatic castration-resistant prostate cancer (mCRPC) treated with cabozantinib
    Meeting Abstract

    Fox, J. J.; Haupt, E. C.; Humm, J.; Autio, K. A.; Rathkopf, D. E.; Vargas, H. A.; Schöder, H.; Hricak, H.; Larson, S. M.; Scher, H. I.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Evaluating 18F-16B-fluoro-5α-dihydrotestosterone (FDHT) and FDG-PET as a measure of disease progression in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Schneider, C. W.; Schöder, H.; Humm, J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; Haupt, E. C.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma
    Journal Article

    Burger, I. A.; Vargas, H. A.; Goldman, D. A.; Gonen, M.; Kumar, A.; Zelenetz, A. D.; Schöder, H.; Hricak, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2013)

    Fulltext@MSK | Save
  • Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration
    Journal Article

    Vargas, H. A.; Burger, I. A.; Donati, O. F.; Andikyan, V.; Lakhman, Y.; Goldman, D. A.; Schöder, H.; Chi, D. S.; Sala, E.; Hricak, H.
    International Journal of Gynecological Cancer (2013)

    Fulltext@MSK | Save
  • Split-dose technique for FDG PET/CT-guided percutaneous ablation: A method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness
    Journal Article

    Ryan, E. R.; Sofocleous, C. T.; Schoder, H.; Carrasquillo, J. A.; Nehmeh, S.; Larson, S. M.; Thornton, R.; Siegelbaum, R. H.; Erinjeri, J. P.; Solomon, S. B.
    Radiology (2013)

    Fulltext@MSK | Save
  • The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration
    Journal Article

    Burger, I. A.; Vargas, H. A.; Donati, O. F.; Andikyan, V.; Sala, E.; Gonen, M.; Goldman, D. A.; Chi, D. S.; Schoder, H.; Hricak, H.
    Gynecologic Oncology (2013)

    Fulltext@MSK | Save
  • 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) PET as a prognostic biomarker for survival in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Jia, X.; Heller, G.; Schoder, H.; Humm, J.; Haupt, E. C.; Schneider, C.; Scher, H. I.; Larson, S. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Comparison of PSA, FDG-PET, and Prostate Cancer Working Group 2 (PCWG2) criteria to interpret apparent progression on first post-treatment bone scan
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Haupt, E. C.; Schoder, H.; Scher, H. I.; Larson, S. M.; Morris, M. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Advances in oncologic imaging: Update on 5 common cancers
    Journal Article

    Akin, O.; Brennan, S. B.; Dershaw, D. D.; Ginsberg, M. S.; Gollub, M. J.; Schoder, H.; Panicek, D. M.; Hricak, H.
    CA - A Cancer Journal for Clinicians (2012)

    Fulltext@MSK | Save